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Abstract
Background: Overweight and obesity are linked with Binge Eating Disorder (BED). Effective interventions to
significantly reduce weight, maintain weight loss and manage associated pathologies like BED are tipically
combined treatment options (dietetic, nutritional, physical, behavioral, cognitive-behavioral, pharmacological,
surgical). Significant difficulties with regard to availability, costs, treatment adherence and long-term efficacy are
present. Particularly Cognitive Behavioral Therapy (CBT) is the therapeutic approach indicated both in in-patient
and in out-patient settings for BED. In recent years systemic and systemic-strategic psychotherapies have been
implemented to treat patients with obesity and BED involved in familiar problems. Particularly a brief protocol for
the systemic-strategic treatment of BED, using overall the strategic dialogue, has been recently developed.
Moreover telemedicine, a new promising low cost method, has been used for obesity with BED in out-patient
settings in order to avoid relapse after the in-patient step of treatment and to keep on a continuity of care with
the involvement of the same clinical in-patient team.
Methods: The comparison between CBT and Brief Strategic Therapy (BST) will be assessed in a two-arm
randomized controlled clinical trial. Due to the novelty of the application of BST in BED treatment (no other RCTs
including BST have been carried out), a pilot study will be carried out before conducting a large scale randomized
controlled clinical trial (RCT). Both CBT and BST group will follow an in-hospital treatment (diet, physical activity,
dietitian counseling, 8 psychological sessions) plus 8 out-patient telephone-based sessions of psychological support
and monitoring with the same in-patient psychotherapists. Primary outcome measure of the randomized trial will
be the change in the Global Index of the Outcome Questionnaire (OQ-45.2). Secondary outcome measures will be
the percentage of BED patients remitted considering the number of weekly binge episodes and the weight loss.
Data will be collected at baseline, at discharge from the hospital (c.a. 1 month after) and after 6-12-24 months
from the end of the in-hospital treatment. Data at follow-up time points will be collected through tele-sessions.
Discussion: The STRATOB (Systemic and STRATegic psychotherapy for OBesity), a comprehensive two-phase
stepped down program enhanced by telepsychology for the medium-term treatment of obese people with BED
seeking intervention for weight loss, will shed light about the comparison of the effectiveness of the BST with the
gold standard CBT and about the continuity of care at home using a low-level of telecare (mobile phones).
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Background
One of the most important medical and public health pro-
blems of our time is represented by obesity [1]. It is widely
considered as a chronic pathology and a risk factor for
many medical complications such as endocrinological,
pneumological, cardiovascular, and orthopedic diseases
[2-8]. Overweight and obesity are also traditionally con-
nected with Binge Eating Disorder (BED), psychopathology
characterized by frequent and persistent episodes of binge
eating with the key feeling of losing the control and the sig-
nificative distress due to the absence of regular compensa-
tory behaviors such as in the patients with bulimia [9].
Effective interventions to significantly reduce weight, main-
tain weight loss and reduce related pathologies like BED
are tipically combined treatment options (dietetic, nutri-
tional, physical, behavioral, cognitive-behavioral, pharma-
cological, surgical). Significant difficulties in these kinds of
approaches have been underlined with regard to availabil-
ity, costs, treatment adherence and long-term efficacy [10].
Even if the combined treatment options are the gold stan-
dard in weight loss, most overweight and obese individuals
regain about one third of the weight lost with treatment
within 1 year [11] and they will typically come back to
baseline in 3 to 5 years [12-14].
About the psychological treatment of BED, Cognitive
Behavioral Therapy (CBT) and Interpersonal Psychother-
apy (IPT) are the psychotherapies more indicated in the
Eating Disorder field [9]. Particularly CBT is the therapeu-
tic approach indicated both in in-patient and in out-
patient settings for BED [15-27].
The prevalence and spread of CBT is not under discus-
sion, in recent years systemic, strategic and systemic-stra-
tegic psychotherapies have been implemented to treat
patients with obesity and BED, overall when the pathology
includes familiar characteristics and problems [26-30].
Particularly a brief protocol for the systemic-strategic
treatment of BED, using overall the typical brief techni-
ques such as the strategic dialogue, has been recently
developed by Nardone and Portelli in the Handbook of
Brief Strategic Therapy (BST) [31] and other contributions
[32,33].
In order to deal with problems of weight regain and
treatment relapses after 12-24-36 months, telemedicine,
a new promising low cost method, has been used for
obesity with BED in out-patient settings. This enhances
the treatment after in-patients rehabilitation and keeps
continuity of care through the involvement of the same
clinical in-patient team [34-37].
Taking into account this scenario, we developed the
STRATOB study (Systemic and STRATegic psychother-
apy for OBesity), a comprehensive two-phase stepped
down program enhanced by telepsychology for the med-
ium-term treatment of obese people with BED seeking
intervention for weight loss. The key aspects of the
STRATOB study are the hospital-based intensive treat-
ment and the continuity of care at home using a low-
cost level of telecare (mobile phones). Many treatments
delivered using new technologies, such as web-sites,
e-mails, chat lines, videoconferences, UMTS mobile-
phones and traditional telephones could represent a
valid integration for traditional psychotherapy reducing
expensive and time-consuming clinical visits and
improving adherence to prescribed psychological, diete-
tic and medical treatments through extended monitor-
ing and support [10,12,34,38-46].
This paper describes the design of the STRATOB
study, a small scale two-arm randomized controlled clini-
cal trial (RCT). The main aim of this study will be to
compare the effectiveness of the BST [31-33] with the
gold standard CBT [26,47-53] in a in-patient and tele-
phone-based out-patient program for a sample of obese
people with BED seeking treatment for weight reduction.
Methods
The comparison between the CBT and BST will be
assessed in a two-arm randomized controlled clinical
trial. Participants will be randomly allocated in 2 groups:
1) CBT group: in-hospital treatment (diet, physical
activity, dietitian counseling, 8 sessions of CBT) plus 8
out-patient telephone-based sessions of CBT-oriented
psychological support and monitoring with the same
CBT in-patient psychotherapists;
2) BST group: in-hospital treatment (diet, physical
activity, dietitian counseling, 8 sessions of BST) plus 8
out-patient telephone-based sessions of BST-oriented
psychological support and monitoring with the same
BST in-patient psychotherapists;
The Medical Ethics Committee of Istituto Auxologico
Italiano approved the study protocol and the Informed
Consents.
The rehabilitation program considered in this study
will have a total duration of 7 months and consists of
two stepped down phases: in-patient (1 month) and out-
patient (the following 6 months).
During the in-patient phase, participants will undergo
an intensive four-week hospital-based and medically-
managed rehabilitation program for weight reduction.
Along this period, participants will live in a hospital
located on a mountain highland and far away from towns
and cities. Visits from family members and friends are
allowed only in the afternoon. All patients will be placed
on a hypocaloric nutritionally balanced diet tailored to
the individual after consultation with a dietitian (energy
intake around 80% of the basal energy expenditure esti-
mated according to the Harris-Benedict equation and a
macronutrient composition of about 16% proteins, 25%
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fat and 59% carbohydrates). Furthermore, they will
receive nutritional counseling provided by dietitians, psy-
chotherapy provided by psychologists-psychotherapists
(well trained in CBT and BST approaches) and have phy-
sical activity training provided by physiotherapists.
Nutritional rehabilitation program aims to improve and
promote change in eating habits and consists of both
individual sessions (dietary assessment, evaluation of
nutrient intake and adequacy, nutritional and anthropo-
metric status, eating patterns, history of overweight,
readiness to adopt change) and group sessions (45 min-
utes each session, twice a week, including: information
on obesity and related health risks, setting of realistic
goals for weight loss, healthy eating in general, general
nutrition and core food groups, weight management and
behavior change strategies for preventing relapse).
Psychotherapy will be provided twice a week in indivi-
dual setting. CBT individual sessions, lasting 45 minutes
each, are mainly based on the cognitive-behavioral
approach described by Cooper and Fairburn [53] and
emphasize the techniques of self-monitoring, goal setting,
time management, prompting and cueing, problem sol-
ving, cognitive restructuring, stress management and
relapse prevention. BST individual sessions, lasting 45
minutes each, are mainly based on the brief strategic
approach described by Nardone and colleagues [31-33]
and emphasize the techniques of working on “attempted
solutions” (such as keeping control by abstaining from
food and continuously striving to exert self-control with
a subsequent loss of control), using reframing maneuvers,
inducing fear of fasting rather then bingeing, understand-
ing what is maintaining and worsening the problem, etc.
(p. 105-105, [31]).
Physical activity will take place once a day except for
week-end and consists of group programs (20 subjects)
based on postural gymnastics, aerobic activity and walks
in the open. In-patients with specific orthopedic compli-
cations will carry out individual activities planned by phy-
siotherapists and articulated in programs of physical
therapy, assisted passive and active mobilization and iso-
kinetic exercise.
At the end of the in-patient step low to moderate
weight losses will be expected and it is important to
underline that weight loss is not the primary goal of the
in-patient program (each patient is made clear about this
point at the very beginning of the treatment). Beyond the
medical management of metabolic risk factors for health
such as type 2 diabetes, developing a sense of autonomy
and competence will be the primary purposes of the in-
hospital interventions. Skills and tools for change will be
provided to patients and they will be supported in assign-
ing positive values to healthy behaviors and also in align-
ing them with personal values and lifestyle patterns.
Just after discharge, participants will have 4 telephone
calls with their in-patient psychotherapists along 2
months. From the 3rd to the 6th month sessions will be
scheduled every 30 days. During tele-sessions, psy-
chotherapists will test the out-patients’ progress, their
mood, the maintenance of functional alimentary and
physical activity habits, the loss/increase of weight and
will discuss about critical moments. Some research indi-
cates that changes in behavior (eating and exercise) often
follow discrete moments which have been variably
described as life events or life crises [54]. Life events can
lead to weight loss but also to weight gain and qualitative
research shows that it is not the event per se that results
in behavior change but the ways in which this event is
appraised, interpreted and managed by the individual
[55]. Psychotherapists (both CBT and BST) will have
thus the opportunity to discuss with their patients in
remote settings about the significant events during the
telephone calls and will cognitively reconstruct dysfunc-
tional appraisals in functional ways. In particular, phone-
sessions with the psychotherapists will aim to consolidate
strategies and abilities acquired during the in-patient
phase, to improve self-esteem and self-efficacy, to sup-
port motivation, to prevent relapse and to provide pro-
blem-solving and crisis counseling.
As underlined, in the out-patient step of the STRA-
TOB program great relevance will be given to the clini-
cian-patient relationship as an important medium and
vehicle of change [56]. After discharge, out-patients will
begin to experience the autonomy and competence to
change they will have developed during the in-patient
phase and inevitably face resistances and barriers. Out-
patients will be supported by telephone by the psy-
chotherapists who will have attended them during the
in-hospital phase in exploring resistances and barriers
they experience and in finding functional pathways to
cope. Furthermore, out-patients will be helped to experi-
ence mastery in terms of the health behavior change
that needs to be engaged.
Recruitment of the study population
One hundred consecutive female in-patients with obe-
sity and BED in the age range of 18-65 years, who will
be referred to a single clinical center (Saint Joseph Hos-
pital - Istituto Auxologico Italiano IRCCS) for weight-
loss treatment, will be asked and screened for admission
to the study. Patients will be sequentially recruited.
Inclusion and exclusion criteria
In-patients will be eligible when they will meet the follow-
ing inclusion criteria at the admission to the hospital:
1) age between 18 and 65 years; 2) obesity according to
the WHO criteria (BMI ≥ 30); 3) BED (DSM-IV-TR
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criteria) and 4) written and informed consent to partici-
pate. Exclusion criteria for the study are: 1) other severe
psychiatric disturbance diagnosed by DSM-IV-TR criteria;
2) concurrent medical condition not related to obesity.
SCID (Structured Clinical Interview for DSM-IV-TR Dis-
orders) I and II [57] will be used as screening tools for psy-
chiatric disorders and will be administered by an
independent clinical psychologist as part of his work.
Randomization procedure
All participants will be randomly assigned to the CBT or
BST group. The randomization scheme will be gener-
ated using the Web site Randomization.com (http://
www.randomization.com). Randomization will occur
after the baseline measurements.
Patient Assessment and Measurements
Primary outcome measure of the randomized trial will
be the change in the Global Index of the Outcome
Questionnaire (OQ 45.2).
Secondary outcome measures will be the percentage of
BED patients remitted considering the number of
weekly binge episodes and the weight loss. Data will be
collected at baseline, at discharge from the hospital (c.a.
1 month after) and after 6-12-24 months from the end
of in-hospital treatment.
Weight will be assessed with the participant in light-
weight clothing with shoes removed on a balance beam
scale.
Data collected at follow-up time points will be col-
lected through tele-sessions.
Psychological and behavioral assessment
Participants will complete the Outcome Questionnaire
(OQ 45.2) - Italian translation and validation [58,59] at
entry to the study and at discharge from the hospital
with a self-report procedure. The number of weekly
binge episodes will be assessed with a self-report proce-
dure at entry to the study and at discharge from the
hospital. At 6-12-24 month follow-up data will be col-
lected via telephone during the tele-sessions.
Outcome Questionnaire (OQ 45.2)
The OQ 45.2 is a self report questionnaire developed by
Michael Lambert in 1996 [60]. The OQ 45 items version
is a measure of outcome and it is designed in order to
collect repeated measures of patient progress during psy-
chotherapy and after its conclusion. This instrument is
one of the most used in psychotherapy research in the
U.S. [61]. The OQ 45.2 is composed by 45 items that
form 3 scales: Symptom Distress (SD), Interpersonal
Relations (IR) e Social Role (SR), and a Global Index. The
OQ 45.2 is proposed as a brief screening and outcome
scale that tries to assess the subjective experience of a
person, as well as the way he or she functions in the
world [60]. The choice of this questionnaire has to take
into account the need to measure a change in a short
time (1 month of in-patient treatment) due to psy-
chotherapeutic activities. The Italian version of the
OQ-45.2 appears promising as a measure of general psy-
chological distress, and it could be used to measure the
psychotherapy outcome in routine clinical practice. So
the Outcome Questionnaire-45 was developed as a brief
measure of client progress in psychotherapy to address
the need for accountability in the era of managed care
and to improve upon extant outcome measures.
The investigator involved in administering and inter-
preting the OQ45.2 will be blinded to treatment
assignment.
Psychotherapists and Treatment Fidelity
Treatments will be delivered by 4 experienced and certi-
fied psychotherapists from diverse backgrounds with
specific training in CBT and BST. Psychotherapists will
receive monthly supervision by senior certified psy-
chotherapists to ensure competent and uniform treat-
ment delivery.
Sample size calculation and statistical analysis
Due to the novelty of the application of BST in BED
treatment, no other RCTs including BST have been car-
ried out. So this RCT will be similar to a pilot study, typi-
cally defined as small scale preliminary study, and
according to Lackey and Wingate [62], a pilot work may
use at least the 10% of the sample required. Using an A-
priori Sample Size Calculator for Student’s t-Test
(G*Power 3.1.2 software), 394 participants per group will
be needed to detect a difference with an estimated Effect
Size (Cohen’s d) of 0.2, an alpha of 0.05 two-sided, a
desired statistical power of 0.80. We decided not to make
assumptions on sidedness not having previous results
about comparison between CBT and BST. Taking into
account the need of at least 10% of the sample required
(788 individuals, n = 394 per group), 80 persons (n = 40
per group) will be considered enough.
Weight data will be analyzed with an intention-to-
treat (ITT) approach with dropouts assumed to have
regained 0,3 kg per month, an assumption already used
in previous studies [12,63]. Differently, missing data in
the other variables will be replaced with baseline obser-
vation carried forward (BOCF) or last observation car-
ried forward (LOCF) as appropriate, assuming no
improvement for non-responders patients.
The independent samples t test will be used to examine
between-group differences in OQ variables and weight at
all time-points. Change scores will be also examined. Chi-
square will be used to test the association between treat-
ment groups and number of weekly binge episodes ≥ 2 at
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6 months. Corrected effect sizes (Hedges) and 95% Confi-
dence Interval will be calculated for both between-group
and with-in group differences.
All data analyses will be performed using the Statisti-
cal Package for the Social Sciences (version 16.0; SPSS,
Inc., Chicago, IL).
Discussion
Due to the novelty of Brief Strategic Therapy (BST) in
the treatment of Binge Eating Disorders, no well defined
hypothesis have been established about the possible con-
tribution of this kind of therapy in comparison with Cog-
nitive Behavior Therapy (CBT), the “gold standard”
psychological treatment for BED. With the development
of a brief systemic-strategic clinical protocol for treat-
ment of BED [31-33], new interventions in the field of
eating disorders are available and have to be evaluated.
Systemic and systemic-strategic psychotherapies such as
BST traditionally focus on systemic-family problems and
contexts and these areas of interventions could represent
a real added value in comparison with CBT. Moreover,
BST sessions could emphasize the techniques of working
on “attempted solutions”, using reframing maneuvers,
inducing fear of fasting rather then bingeing, understand-
ing what is maintaining and worsening the problem, etc.
(p. 105-106, [31]). This focus on “attempted solutions”,
that in the typical BED are related to dysfunctional habits
such as “trying to keep control by abstaining from food
and continuously striving to exert self-control with a sub-
sequent loss of control”, could generate some differences
between the BST and the CBT approach about the remis-
sion of weekly binge episodes at 6-12-24 months (during
the in-patient phase patients will do not cope with the
binge temptations due to the lack of them in a safe place
like the hospital). Moreover the focus of BST on symp-
toms reduction (in particular anxiety and depression) in
short time (traditionally 6-12 months) could generate sig-
nificant difference between CBT and BST in the OQ 45.2
Symptom Distress (SD) scale.
The real therapeutic impact of CBT and BST could be
significantly reduced by the use of a non-traditional set-
ting in the second part of the trial. Even if telecare
could represent a great opportunity for the continuity of
treatments “moving the healthcare where it really
needs”, the limitations of non-verbal communications,
due to the use of telephone sessions, could influence the
CBT and BST protocols in different ways that have to
be investigated.
A possible limitation in this trial is the small sample size.
Even if this is the first study that compared CBT with BST
in the treatment of BED, larger clinical trials will be
needed in order to evaluate both the effectiveness of inte-
grated psychotherapies (such as the traditional CBT com-
bined with BST or IPT) and the use of new technologies
in the clinical field (from the “low technology” telephone
to the “medium technology” clinically oriented SMS,
MMS, e-mail, chat, web sources, till the “high technology”
web 2.0 or virtual and augmented realities) [64-70].
Moreover generalization of research findings will be lim-
ited because the STRATOB trial will be a single-centre
randomized controlled study. Future multi-centre trials
should extend both the use of alternative models of psy-
chological support or psychotherapy, i.e. BST, and the
implementation of new technologies, in order to find the
best combination of the variables involved (psychothera-
peutic model, level of technology, number of sessions,
etc.).
Taking into account that traditional interventions for
BED patients with obesity typically fails because of low
compliance with clinical programs, continuous monitoring
and psychological support are needed. This study will
improve the evidence-based knowledge of how CBT and
BST may enhance the long-term efficacy of clinical inter-
ventions for BED and weight loss using telecare settings
too.
Due to the growing development of technologies in
the clinical applications, we are moving towards a new
“health care everywhere” approach, where clinicians
could provide their treatments in both traditional clini-
cal settings (public and private hospitals, clinics, ser-
vices, etc.) and innovative clinical settings (remote out-
patients’ clinics, tele-health and e-health based settings)
[65,68,70-72].
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